Details for New Drug Application (NDA): 017447
✉ Email this page to a colleague
The generic ingredient in NORPACE is disopyramide phosphate. There are nineteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the disopyramide phosphate profile page.
Summary for 017447
Tradename: | NORPACE |
Applicant: | Pfizer |
Ingredient: | disopyramide phosphate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 017447
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
NORPACE | disopyramide phosphate | CAPSULE;ORAL | 017447 | NDA | Pfizer Laboratories Div Pfizer Inc | 0025-2752 | 0025-2752-31 | 100 CAPSULE, GELATIN COATED in 1 BOTTLE (0025-2752-31) |
NORPACE | disopyramide phosphate | CAPSULE;ORAL | 017447 | NDA | Pfizer Laboratories Div Pfizer Inc | 0025-2762 | 0025-2762-31 | 100 CAPSULE, GELATIN COATED in 1 BOTTLE (0025-2762-31) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 100MG BASE | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AB | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 150MG BASE | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AB | RLD: | Yes |
Complete Access Available with Subscription